Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term management strategies for gastroesophageal reflux symptoms in primary care
2006-002867-19Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole in gastroesophageal reflux disease (GERD) (3 arms), sponsored by AstraZeneca. Primary endpoint: Number of treatment failures during maintenance phase. Started Jul 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-002867-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002867-19.